Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Sep;74(9):812-814.
doi: 10.1016/j.rec.2021.04.005. Epub 2021 Apr 27.

Acute myocarditis after administration of the BNT162b2 vaccine against COVID-19

[Article in English, Spanish]
Javier Bautista García  1 , Pedro Peña Ortega  2 , José Antonio Bonilla Fernández  2 , Aridane Cárdenes León  2 , Luis Ramírez Burgos  2 , Eduardo Caballero Dorta  2
Affiliations
Case Reports

Acute myocarditis after administration of the BNT162b2 vaccine against COVID-19

[Article in English, Spanish]
Javier Bautista García et al. Rev Esp Cardiol (Engl Ed). 2021 Sep.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
A: electrocardiogram showing sinus rhythm with a reduced PR interval in I and V5-V6 and diffuse ST elevation with upward concavity. B: electrocardiogram in sinus rhythm with < 1 mm elevation and upward concavity in V3-V6 and negative T waves in I, II, aVL, and V3-V6.
Figure 2
Figure 2
Magnetic resonance image with late enhancement in the lateral mediastinal region and edema on T2-enhanced STIR sequences.
See this image and copyright information in PMC

Comment in

Comment on

References

    1. Su J.R., McNeil M.M., Welsh K.J., et al. Myopericarditis after vaccination, vaccine adverse event reporting system (VAERS), 1990-2018. Vaccine. 2021;39:839–845. - PubMed
    1. Mele D., Flamigni F., Rapezzi C., et al. Myocarditis in COVID-19 patients: current problems. Intern Emerg Med. 2021 doi: 10.1007/s11739-021-02635-w. - DOI - PMC - PubMed
    1. Salamanca J., Díez-Villanueva P., Martínez P., Cecconi A., et al. COVID-19 “fulminant myocarditis” successfully treated with temporary mechanical circulatory support. JACC Cardiovasc Imaging. 2020;13:2457–2459. - PMC - PubMed
    1. Talotta R. Do COVID-19 RNA-based vaccines put at risk of immune-mediated diseases? In reply to “Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases”. Clin Immunol. 2021;224:108665. - PMC - PubMed
    1. Polack F.P., Thomas S.J., Kitchin N., et al. Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine. N Engl J Med. 2020;383:2603–2615. - PMC - PubMed